These pathways are leiomyosarcoma-relevant, given that leiomyosarcomas are characterized by a high frequency of alterations in tumor suppressor gene RB1, which negatively regulates transcription factor E2F1 (18). The gene discussed is E2F1; the disease is leiomyosarcoma.